Sangamo Biosciences CEO Alexander Macrae's 2020 pay slips 4% to $3.8M
Sangamo Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 2, 2021
Sangamo Biosciences reported fiscal year 2020 executive compensation information on April 2, 2021.
In 2020, six executives at Sangamo Biosciences received on average a compensation package of $2.1M, a 1% decrease compared to previous year.
Average pay of disclosed executives at Sangamo Biosciences
Alexander D. Macrae, Chief Executive Officer, received $3.8M in total, which decreased by 4% compared to 2019. 39% of Macrae's compensation, or $1.5M, was in option awards. Macrae also received $511K in non-equity incentive plan, $682K in salary, $1.1M in stock awards, as well as $5.6K in other compensation.
For fiscal year 2020, the median employee pay was $174,051 at Sangamo Biosciences. Therefore, the ratio of Alexander D. Macrae's pay to the median employee pay was 22 to one.
D. Mark McClung, Executive Vice President, Chief Business Officer, received a compensation package of $2.7M. 44% of the compensation package, or $1.2M, was in option awards.
R. Andrew Ramelmeier, Executive Vice President, Technical Operations, earned $1.5M in 2020, a 39% increase compared to previous year.
Sung H. Lee, Chief Financial Officer, received $1.4M in 2020, which decreases by 43% compared to 2019.
Stéphane Boissel, Former Executive Vice President, Corporate Strategy, earned $1.4M in 2020, a 3% decrease compared to previous year.
Gary H. Loeb, General Counsel, received $1.4M in 2020, which decreases by 32% compared to 2019.
Related executives
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
Sung Lee
Sangamo Biosciences
Chief Financial Officer
Gary Loeb
Sangamo Biosciences
General Counsel
D McClung
Sangamo Biosciences
Chief Operating Officer
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
Stéphane Boissel
Sangamo Biosciences
Former Executive Vice President, Corporate Strategy
You may also like
Source: SEC filing on April 2, 2021.